News

Latest news: Quotient Sciences Completes Integration of Drug Substance Into Translational Pharmaceutics Platform

Access Press Release

Search

30 results for "Candidate Selection"

From candidate selection through to proof-of-concept

Building a robust understanding of your API characteristics matched against your development programme goals, supports the efficient transition of drug products from candidate selection through to proof-of-concept. Starting @ 4pm (BST-UK), 11pm (ET), 8am (PT) and 6pm (BST-UK), 1pm (ET), 10am (PT)

The Integration of Drug Substance and Drug Product

This webinar highlights how a fully integrated program can speed up transition from candidate selection to proof of concept and shorten the pathway to clinical development.

Accelerating Development Through Integrated Drug Substance & Drug Product Strategies | April 28th Webinar

Register today for our live webinar on April 28 to learn how a fully integrated program can speed up transition from candidate selection to proof of concept and shorten the pathway to clinical development.

Drug Substance

Pharmaceutical CDMO & CRO | Quotient Sciences

At a glance

Boston Lunch Seminar: Integrated Drug Substance & Drug Product Strategies- May 11

Save your spot for our upcoming lunch seminar in Cambridge, MA on May 11 entitled: "Accelerating Development Through Integrated Drug Substance & Drug Product Strategies: Fully integrated programs to shorten the clinical pathway"

DCAT Lunch Seminar: Integrated Drug Substance & Drug Product Strategies

Save your spot at our DCAT Week lunch seminar on March 23rd, entitled: Accelerating Development Through Integrated Drug Substance & Drug Product Strategies: Fully integrated programs to shorten the clinical pathway

Candidate Development

Pre-formulation screening

Pre-formulation screening

Pre-formulation screening

Oncology

CPhI NA Lunch Seminar: Moving Drug Substance Off the Critical Path

Save your spot at our CPhI North America lunch seminar on May 18, entitled: Moving Drug Substance Off the Critical Path- Streamlined Strategies to Accelerate to First-in-Human & Beyond

Moving Drug Substance Off the Critical Path — Streamlined Strategies to Accelerate to First-in-Human & Beyond

Join Quotient’s Director of Drug Development Consulting, Dr Stephen McQuaker Vice President of Bioanalysis, Dr Stuart McDougall, as he explores case studies to demonstrate how drug substance and drug product development plans can be accelerated through innovative science and expertise to get drug substance off the critical path.

Biopharm America 2021 Conference

Quotient Sciences will be attending the Biopharm America Conference from September 20-23, 2021.

CPhI North America 2022

Quotient will be exhibiting at CPhI North America 2022 in Philadelphia on May 17-19, 2022.

Project Management at Quotient Sciences

Quotient is an innovative drug development and manufacturing partner supporting clients from candidate selection to commercial launch. With expertise in end-to-end Project Management and integrated project teams, we make drug development easier for our customers and dramatically reduce the time and cost of getting new medicines to patients.

BIO Happy Hour Seminar: Moving Drug Substance Off the Critical Path

Save your spot at our BIO happy hour seminar on June 15th, entitled: Moving Drug Substance Off the Critical Path- Streamlined Strategies to Accelerate to First-in-Human & Beyond

Drug Substance Synthesis and Manufacturing

Tactical deployment of best-in-class synthesis technologies to minimize chemistry costs and move your drug substance supply off the critical path.

Accelerating molecules through to Proof-of-Concept, with an integrated early development program

This webinar highlights how a fully integrated development plan can bring together the needs of the drug product team and the clinical development team.

Outsourced Pharma Capacity Update

Join Quotient at the upcoming virtual Outsourced Pharma Capacity Update Event on March 1st-3rd.

Solubility Webinar October 21st

Register today for our solubility focused webinar on October 21st.

Solubility Webinar October 26th

Register today for our solubility focused webinar on October 26th.

Solubility Webinar Series

Register today for our solubility focused webinar series taking place on October 21st, 26th, or 28th for our Solubility focused webinar entitled: Accelerated development strategies for poorly soluble molecules

Pharmaceutical Spray Drying to Overcome Poor Drug Solubility

Overcoming poor drug solubility is a common and challenging task facing the formulation scientist today.

Solubility Webinar October 28th

Register today for our upcoming solubility focused webinar on October 28th.

Getting it Right Early- The Importance of Biopharmaceutics in Early Drug Development - Webinar

Join us for a webinar to learn effective strategies that biotech and pharmaceutical companies are using to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline and explore alternative approaches for accelerating your early development plan.

Getting it Right Early- The Importance of Biopharmaceutics in Early Drug Development - Boston

Join us for a complimentary lunch seminar to learn effective strategies that biotech and pharmaceutical companies are using to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline and explore alternative approaches for accelerating your early development plan.

Live Webinar: Improving Solubility and Accelerating Drug Development through Integrated Programs

Join Quotient & Lonza on February 23rd at 8am PST / 11am EST for a live webinar entitled: Improving Solubility and Accelerating Drug Development through Integrated Programs

Get in touch
Humanity can’t afford to wait, so neither can we.
Let’s talk.